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Objectives: Humans have been using plants as natural medicines since prehis-
toric times. Bunium persicum is a rich source of oils with different biological
activities such as antioxidative and antimicrobial activities. The aim of this study
is to evaluate the antihematotoxic and antioxidative effects of the differential
extracts of B. persicum against leukemic blood induced hematotoxicity in an
animal model.
Methods: This study was performed on animals, which were divided into several
groups: normal control, disease control, and groups that were administered with
differential extracts of plants. We measured the concentration of free radical
[reactive oxygen species (ROS)] and hematological parameters as blast cells from
the tibia and femur in different groups.
Results: The ROS level and blast cells count were higher in disease control groups
than in groups treated with varying amounts of B. persicum extract and the
normal group. Moreover, there was an imbalance in hematological parameters in
untreated and treated groups with a correlation between free radicals and plant
extract administration.
Conclusion: These findings may indicate a possible link between free radicals
and hematotoxicity and blast cells, while depicting a potential therapeutic role
for B. persicum against ROS-induced hematotoxicity.1. Introduction
Plants have been used as medicines since the dawn of
civilization [1]. Bunium persicum is a high-value herba-
ceous spice of the parsley family (Apiaceae) used as a spicebch@qau.edu.pk (I. Murta
ted under the terms of the
) which permits unrestrict
operly cited.
ase Control and Preventionto add flavor to certain dishes and delicacies, and bakery
perennial aromatic and medicinal umbel lifer [2]. B. per-
sicum, also known as “black cumin” in English, is a
common plant that iswidely distributed inGilgit, Baltistan,
Chitral, Swat, Hazara, and Baluchistan in Pakistan [2,3].za).
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Antihematotoxic role of Bunium persicum extract 359B. persicum is a rich source of essential oils including
terpenoids and alkaloids with different biological ac-
tivities such as antioxidant and antimicrobial effects [4].
Essential oils found in B. persicum have antifungal [5]
and antimicrobial activities [6]. Seeds of B. persicum
are rich in phenolic compounds and g-terpinene, which
exhibit potential antioxidant properties and can act as
efficient free radical scavengers [7].
Reactive oxygen species (ROS) are produced during
natural metabolic processes in the form of superoxide
(O2), hydrogen peroxide (H2O2), hydroxyl radical
(OH.), and singlet oxygen (1O2), which attack biological
molecules leading to cell or tissue injury [8]. ROS have
a pivotal role in signal transduction but in excess can
contribute to fetal toxicity by deregulation of signal
transduction and/or by oxidative damage to cellular
macromolecules such as lipids, proteins, DNA, and
RNA. Oxidative stress can lead to a number of human
diseases such as atherosclerosis, inflammatory diseases,
neurodegenerative disorders, and different types of
cancers [9,10]. Wan and Winn [11] have reported that
ROS play a major role in benzene-mediated fetal hem-
atotoxicity in mice.
These oxidative stresses are encountered by antioxi-
dant compounds that prevent or delay the peroxidation
of fats. Different types of synthetic antioxidants such as
butylatedhydroxytoluene, butylatedhydroxyanisole,
propyl gallate, and tertbutylhydroquinone are used as
additives in food industries. These antioxidants, how-
ever, have been reported by researchers to be potential
carcinogens and can cause external and internal bleeding
and finally death owing to their effects on the blood
coagulation factor [12]. Because of the hazardous ef-
fects of synthetic antioxidant additives, consumers have
shown an increasing tendency to use additives from
natural resources such as plant essential oils in foods,
beverages, and cosmetics. The seeds of B. persicum are
rich in essential oils, which have a potent antioxidant
activity and can be used as natural antioxidants [13].
In the present study, we examined the effects of
different fractions of B. persicum seed extracts in
leukemic blood induced hematotoxicity in rats. To
achieve this goal, different seed fractions of B. persicum
as well as ethyl acetate, butanol, hexane, and aqueous
fractions were used, and their effects on various pa-
rameters including hematological parameters, ROS,
aberrant protein expression, and blast cells of bone
marrow were studied.2. Materials and methods
2.1. Plant materials
Plant materials (seeds) were purchased from a market
in Rawalpindi, Pakistan. They were cleaned, washed,
and dried under the shade. The seeds were then ground
into fine powder with a grinder.2.2. Preparation of crude extract and
fractionation
The procedure described by Wube et al [14] was
followed for extraction. Briefly, the powdered residue
(3 kg) was kept in a closed container and extracted with
methanol by maceration for 4 days to obtain the crude
extract (175 g). The solvent containing the crude extract
was filtered with a Whatman filter paper (Number 1) and
evaporated under reduced pressure using a rotary
evaporator and allowed to dry at room temperature. The
maceration process was repeated three times. The dried
extract obtained was suspended in water and extracted
with hexane, ethyl acetate, and butanol solvents subse-
quently using a separating funnel to obtain the ethyl
acetate, butanol, hexane, and aqueous fractions. The
solvent from each fraction was evaporated and allowed
to dry. The dried fractions were kept at 2C in dark
glass bottles for experimentation.
2.3. Ethical considerations
This study was carried out with the approval and
under the strict guidelines of the institutional ethics
committee for the handling of animals.
2.4. Experimental models
Twenty-four albino neonate rats (birth age< 24 hours)
were obtained from the Animal House of the Department
of Biological Sciences, Quaid-i-Azam University, Islam-
abad, Pakistan, and randomly divided into six groups. One
group was designated as the control normal group (Group
C), whereas the other five groups (A, B, D, E, H) were
injected intraperitoneally (i.p.) with fresh leukemic (acute
myeloid leukemia) blood (0.2 mL; age,  24 hours) to
induce hematotoxicity within 13e38 days [15].
2.5. Experimental design and treatment
After the 40th day of injection, the weight of each rat
was accurately measured, and rats were treated as fol-
lows: Group A, 300 mg/kg/d aqueous fraction in 0.5 mL
Tween; Group B, 300 mg/kg/d butanol fraction in
0.5 mL Tween; Group C, 0.5 mL/d of 5% Tween; Group
D, normal with leukemic blood treated, 0.5 mL/d of 5%
Tween; Group H, 300 mg/kg/d hexane fraction in
0.5 mL Tween; Group E, 300 mg/kg/d of rat body
weight ethyl acetate fraction in 0.5 mL Tween. The
dosages were given as i.p. injections for 9 consecutive
days. Table 1 shows the treatment schedule.
2.6. Hematological parameters
After the treatment with plant differential extracts
was completed, all rats were sacrificed on the 10th day
by decapitation, and blood was collected and sent to
North Western Laboratory Peshawar, Pakistan, to
determine the blood parameters: white blood cells dif-
ferential (monocytes, basophils, eosinophils, and neu-
trophils), red blood cells (RBCs; g/dL), and number of
platelets.
Table 1. Treatment schedule.
Group Treatment
A Injected with leukemic blood; treated with
aqueous fraction
B Injected with leukemic blood; treated with
butanol fraction
C Designated as control group (normal); treated
with 0.5 mL of 5% Tween
D Assigned as disease control group; injected with
leukemic blood and treated with 0.5 mL
of 5% Tween
E Injected with leukemic blood; treated with
ethyl acetate fraction
H Injected with leukemic blood; treated with
hexane fraction
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The bone marrow was collected from the both the tibia
and the femur within hours after the rats were sacrificed.
The bones were cleaned from the tissue, and the tips of
each bone were cut down from one side and flushed out
from the other side with 25-gauge needle with phosphate
buffer saline into a falcon tube. The flushing was repeated
several times until the bone turned pale. The filtrate was
centrifuged at 1000 rpm for 10 minutes, and the super-
natant was discarded. The fixative (1:3) acetic alcohol was
added to the falcon tube and was gently mixed then
centrifuged again to obtain a fresh cell button end; next,
fresh fixative was added to obtain cell suspension. A drop
was made from the cell suspension into a clear slide and
allowed to dry. The air-dried smears of bone marrow
aspirate were fixed in methanol for 8 minutes. The slides
were then immersed in Giemsa stain for 10 minutes and
washed with distilled water to remove the extra stain.
Slides were observed under a light microscope (Meiji
Techno MT6200) at 100 magnification.2.8. ROS measurement
The protocol described by Hayashi et al [16] was fol-
lowed for the standard curve formation and ROS detection
in all groups using spectrometric methods. To make
standard solutions, in 0.1M sodium acetate buffer (pH
4.8), DEPPD (R1) was dissolved to obtain a final con-
centration of 100 mg/mL, and ferrous sulfate (R2) was
dissolved in sodium acetate buffer to attain a final con-
centration of 4.37mM. R1 and R2 were mixed at a ratio of
1:25 prior to use to make a mixed solution. Then, 1200 mL
of the mixed solution was added as a starter in a 3-mL
cuvette followed by adding 1000 mL sodium acetate
buffer and 60 mL hydrogen peroxide (H2O2) as positive
control. Instead of H2O2, serum was used for ROS
detection in the rat blood serum. After free incubation of 1
minute, absorbance at 505 nm was observed using the
Agilent 8453 UVeVisible Spectrophotometer (UK).2.9. Statistical analysis
Data are expressed as mean  standard deviation.
SPSS version 16 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses. A p value < 0.05 was
considered statistically significant.3. Results
3.1. Hematological parameters and plant
extracts
Hematological parameters in various study groups
treated with differential extracts of B. persicum seeds
are presented in Table 2 and Figure 1. Group D (disease
control group) showed an increase in monocytes, ba-
sophils, and eosinophils % values and a decrease in %
neutrophils, RBC (g/dL), and platelets count when
compared with their corresponding values among
normal rats. Among the treated (butanol, ethyl acetate
fraction) groups, % monocytes and % basophils
decreased significantly when compared to Group D
(normal leukemic blood induced group). Similarly, a
significant increase was observed in RBCs (g/dL) and
platelet concentration/counts compared with those of
disease controls (Table 2, Figure 1). In the case of
Group A (leukemic treated with aqueous fraction),
platelet levels were observed to be elevated compared
to the disease control group (Group D; Table 2,
Figure 1), whereas % of monocytes and RBCs
decreased.
3.2. Effects of plant extracts on ROS level
Elevated concentrations of free radicals are consid-
ered toxic for biological systems.
The level of free radicals in the hematotoxic group
(Group D) was high compared with that of normal rats
in Group C (Table 2). After the administration of plant
extracts, a significant decrease in ROS was observed
only in Group E, whereas in Group B the decrease was
nearly significant (p Z 0.059).
3.3. Effects of plants extracts on blast cells
Large numbers of blast cells were observed in the
disease control group as compared with the normal
control group. The number of blast cells seen in EFT
and BFT was lower compared with that of the disease
control group but higher than that of the normal control
group (Figure 2).4. Discussion
Regulation of ROS level is essential for maintenance
of normal populations of hematopoietic stem cells and
their differentiation in normal hemopoetic cell lines
[17,18]. ROS in cancer can be targeted by the use of
antioxidant molecules to suppress the high levels of
Table 2. Variation of differential blood parameters and comparative analysis of ROS mean values among normal control,
disease control, and treated groups.
Groups
WBC differential
RBC (g/dL)
Platelet counts
(109/L)% Monocytes Basophils % Eosinophils % Neutrophils
A 29.7  1.25 6.48  0.91 5.75  0.5 6.69  0.76 5.70  0.76 716  28
B 5.4  0.7 4.95  0.88 5.69  0.86 7.47  0.91 5.68  0.52 102  109
C 6.57  0.40 1.0  0.50 5.18  1.1 13.63  0.9 7.6  0.86 851  89
D 31.1  0.90 6.87  1.51 9.43  0.7 6.10  0.30 4.84  0.76 411  44
E 11.2  1.71 4.3  1.02 5.2  0.36 9.77  0.3 6.48  0.37 739  50
H 30.1  0.76 6.48  0.91 5.38  0.58 6.99  0.6 5.35  0.22 538  62
Mean value of absorbance (ROS)
A 0.24  0.025
B 0.25  0.007
C 0.21  0.083
D 0.41  0.067
E 0.24  0.025
H 0.35  0.029
Data are expressed as mean  SD. RBC Z red blood cell; ROS Z reactive oxygen species; WBC Z white blood cell.
Figure 1. Effect of differential fractions extracted from the seeds of Bunium persicum on different hematological parameters
compared from CBC results and free radical concentration in serum. Groups A, B, E, and H were administered intraperitoneally
(i.p.) with nontoxic dose of 300 mg/kg of rat body weight of each fraction in 5% Tween solution for 9 consecutive days. Groups C
and D were assigned as vehicle controls and were only injected (i.p.) with 0.5 mL/d of 5% Tween solution. Mean values were
compared using one-way ANOVA followed by Tukey test. *A p value < 0.05 indicates significant difference from the control
disease (group D) values. (A) Percentage of basophils in different groups. (B) % of eosinophils. (C) % of neutrophils. (D) Numbers
of platelets. (E) RBC counts. (F) % of monocytes. (G) Level of ROS in different groups. ANOVA Z analysis of variance;
CBC Z complete blood count; RBC Z red blood cell; ROS Z reactive oxygen species.
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Figure 2. Bone marrow smear stained with Giemsa stain. The blast cells are indicated by an arrow in each figure. (A) Control
disease. (B) normal. (C) Blast cell in EFT. (D) Blast cells in BFT. BFT Z .
362 T. Ali, et alROS [19]. B. persicum is a rich source of essential oils
including terpenoids, phenolic compounds, and alka-
loids, and is known to have antioxidant and antimicro-
bial properties [4,7]. Different types of synthetic
antioxidants such as butylatedhydroxytoluene, butyla-
tedhydroxyanisole, propyl gallate, and tertbutylhy-
droquinone are used as additives in food industries.
However, researchers have shown that these antioxi-
dants are potential carcinogens and can cause internal
and external bleeding and even death owing to their
effects on blood coagulation factor. Because of these
health-threatening effects of synthetic antioxidants, it
becomes crucial to explore natural antioxidant com-
pounds as safer substitutes. The seeds of B. persicum are
rich in essential oils, which have a potent antioxidant
activity [12]. Based on the antioxidant activity of B.
persicum, we hypothesize that plant extracts may have
antihematotoxic effects via an oxygen species-
dependent mechanism.
In the present investigation, our finding of increased
ROS level compared to the normal group is in agree-
ment with previous reports. The treatment using plant
extracts such as EFT and BFT reduced the ROS level,
suggesting that B. persicum plant extracts have a strong
potential as antioxidants against free radicals. Surpris-
ingly, we found decreased blast cell populations in EFT-
and BFT-treated animals compared to the disease con-
trol animals. This showed a correlation of free radicals
and blast cells; however, this concept may require
further study.Blood is an important index of physiological and
pathological status in man and animals, and the pa-
rameters usually measured are differential leukocyte
(white blood cell) count, RBC count, and platelet counts
[20,21]. In the present study, an imbalance in the blood
picture was observed under diseased conditions. After
the treatment, the action performed by B. persicum ex-
tracts in the regulation of monocytes, eosinophils, neu-
trophils, basophils, and RBCs under toxic conditions,
showed their potential against toxicity.
In summary, we have shown for the first time that B.
persicum plant differential extracts possess antitoxic
and antioxidative properties against leukemic blood
induced hematotoxicity and free radicals, respectively.
These findings suggest and emphasize that ethyl acetate
and butanol fractions from the seed extract of B. per-
sicum could be further characterized as a valuable
therapeutic candidate for the treatment of patients with
AML.Conflicts of interest
None.
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